| Not Yet Recruiting | Sexual Health and Rehabilitation for Women With Metastatic Breast Cancer (SHARE-MC): An Educational Interventi Metastatic Breast Cancer | N/A | 2026-09-18 |
| Not Yet Recruiting | Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at Hi Breast Cancer, Ductal Carcinoma, Estrogen-receptor-positive Breast Cancer | Phase 2 | 2026-09-09 |
| Not Yet Recruiting | Development and Testing of Nutritional Algorithms (NACHO) Nutrition Poor, Nutritional Deficiency, Quality of Life | N/A | 2026-09-01 |
| Not Yet Recruiting | my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults Sarcoma, Osteosarcoma, Ewing Sarcoma | N/A | 2026-08-20 |
| Not Yet Recruiting | The DISCOVER Study Cancer, Cancer Diagnosis | N/A | 2026-07-01 |
| Not Yet Recruiting | Precise Exercise Regimen for Cancer Care (PERCC): A Pilot Study Stage II Lung Cancer, Lung Cancer, Non-small Cell Lung Cancer | N/A | 2026-07-01 |
| Not Yet Recruiting | Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy Cutaneous Squamous Cell Carcinoma, Skin Cancer | Phase 4 | 2026-07-01 |
| Not Yet Recruiting | PH 2 Pemigatinib in SDH-deficient GIST SDH Gene Mutation, Gastrointestinal Stromal Tumor | Phase 2 | 2026-06-01 |
| Not Yet Recruiting | Supporting Health Including Endocrine Treatment for Long Duration Breast Cancer, Breast Cancer - Female, Breast Carcinoma | N/A | 2026-05-01 |
| Not Yet Recruiting | Integrated Smartphone Technology to Alleviate Malignant Pain (I-STAMP) Testing Advanced Cancer, Pain | N/A | 2026-05-01 |
| Not Yet Recruiting | Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReAC HPV-positive Oropharyngeal Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma | Phase 2 | 2026-05-01 |
| Not Yet Recruiting | ALL Backbone in AYAs Acute Lymphoblastic Leukemia, Philadelphia Chromosome-Negative Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia (ALL) | Phase 2 | 2026-04-01 |
| Recruiting | Neoadjuvant Ficerafusp Alfa With Pembrolizumab in Resectable SCC Head and Neck Squamous Cell Carcinoma (HNSCC), Squamous Cell Carcinoma of the Head and Neck | Phase 2 | 2026-03-26 |
| Recruiting | On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety Cancer, Survivorship, Anxiety | N/A | 2026-03-11 |
| Recruiting | Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC Renal Cell Carcinoma, Kidney Cancer, Kidney Neoplasm | Phase 2 | 2026-03-09 |
| Active Not Recruiting | Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial Childhood Cancer Survivors, Cardiotoxicity, Cardiovascular Diseases | N/A | 2026-03-04 |
| Not Yet Recruiting | ACTIVATE: AI-driven Clinical-trial Trial-Information and Viability Assessment Tool for EHRs Cancer | N/A | 2026-02-01 |
| Recruiting | Individualizing Approaches to Surveillance Mammography in Older Breast Cancer Survivors - The I-MAMMO Study Breast Cancer | Phase 2 | 2026-02-01 |
| Not Yet Recruiting | Ph 2 Elacestrant in ER Positive Uterine Sarcomas Uterine Sarcoma, Uterine Leiomyosarcoma, Endometrial Stromal Sarcoma | Phase 2 | 2026-02-01 |
| Recruiting | Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT) Chemotherapy Induced Peripheral Neuropathy (CIPN), Peripheral Neuropathy Due to Chemotherapy, Peripheral Neuropathies | N/A | 2026-01-16 |
| Recruiting | ACT Lung Health Intervention: Phase Two Smoking Cessation, Smoking Behaviors, Smoking, Tobacco | N/A | 2025-11-04 |
| Recruiting | Cryocompression for CIPN Chemotherapy-induced Peripheral Neuropathy, Taxane-Induced Peripheral Neuropathy, CIPN - Chemotherapy-Induced Peripheral Neuropathy | N/A | 2025-10-22 |
| Active Not Recruiting | Better Real-time Information on Documentation of Goals of Care for Engagement in Serious Illness Communication Advanced Cancer, Cancer, End of Life | N/A | 2025-09-15 |
| Recruiting | HEME Home Transfusion Program Leukemia, Myeloma, Myelodysplastic Syndromes | N/A | 2025-09-10 |
| Active Not Recruiting | 177LuPSMA in Renal Cell Carcinoma Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma, Kidney Cancer | Phase 2 | 2025-07-31 |
| Recruiting | Exercise and Nutrition for Older Cancer Survivors and Their Support Person: The Vitality Study Cancer Survivorship | N/A | 2025-07-23 |
| Recruiting | Sleep Treatment Education Program for Cancer Survivors: STEP-Together Insomnia, Insomnia Chronic, Survivorship | N/A | 2025-06-25 |
| Recruiting | Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Lymphoma, Lymphoma, Hodgkin, Lymphoma, Non-Hodgkin | N/A | 2025-06-05 |
| Recruiting | BOLSTER: Learning New Skills to Thrive Gastrointestinal Cancer, Gynecologic Cancer, Advanced Cancer | N/A | 2025-05-12 |
| Recruiting | Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma Neuroblastoma, High-risk Neuroblastoma | N/A | 2025-04-30 |
| Recruiting | Proof-of-Concept Testing of the Cardiovascular Health Equity Through Food (CHEF) Intervention in Childhood Can Childhood Cancer, Childhood Cancer Survivors | N/A | 2025-04-07 |
| Recruiting | EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations Lung Cancer, EGFR Gene Mutation | N/A | 2025-04-01 |
| Recruiting | Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing Acute Leukemia, Leukemia | N/A | 2025-04-01 |
| Recruiting | Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Military Population: The Sentinel Study Cancer Diagnosis | N/A | 2025-03-31 |
| Recruiting | Integrating Pain-CBT Into an mHealth Analgesic Support Intervention for Patients With Chronic Pain From Advanc Pain, Pain Syndrome, Advanced Cancer | N/A | 2025-03-27 |
| Recruiting | REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors Ovarian Cancer, Advanced Ovarian Carcinoma, Fallopian Tube Carcinoma | N/A | 2025-03-17 |
| Active Not Recruiting | Pilot of a Trial Enrollment Diversity Dashboard Leukemia, Acute Leukemia | N/A | 2025-03-01 |
| Active Not Recruiting | Sexual Health and Rehabilitation Online (SHAREonline) Cancer Survivorship, Sexual Function Disturbances | N/A | 2025-02-19 |
| Withdrawn | UNTIRE: Cancer-related Fatigue With Digital Treatment Colorectal Cancer, Fatigue | N/A | 2025-01-30 |
| Recruiting | Dance Study for Post-surgical Pain in Breast Cancer Survivors Breast Cancer, Survivorship, Pain, Postoperative | N/A | 2025-01-22 |
| Recruiting | Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovar Ovarian Cancer, Ovarian Neoplasms, Ovarian Carcinoma | N/A | 2025-01-17 |
| Recruiting | Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin Ovarian Cancer, Ovarian Carcinoma, Endometrial Cancer | Phase 2 | 2024-12-20 |
| Recruiting | The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Underg Rectal Cancer, Colorectal Cancer, Rectal Cancer Stage II | N/A | 2024-12-15 |
| Recruiting | Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE) Blood Cancer, Leukemia | N/A | 2024-12-09 |
| Recruiting | A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Ce Skin Cancer, Cutaneous Squamous Cell Carcinoma (CSCC), Cutaneous Squamous Cell Cancer | EARLY_Phase 1 | 2024-11-26 |
| Recruiting | Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL Lymphoma, Primary Central Nervous System Lymphoma | Phase 1 | 2024-10-18 |
| Completed | Home Transfusion for HEME Hematologic Malignancy | N/A | 2024-10-18 |
| Recruiting | Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer Platinum-resistant Ovarian Cancer, Recurrent Ovary Cancer, Ovarian Cancer | Phase 1 | 2024-10-09 |
| Recruiting | Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Population: The INFORM Study Cancer Predisposition Syndrome, Predisposition, Genetic | N/A | 2024-09-27 |
| Recruiting | ALPINE: Maintenance Letrozole/Abemaciclib Endometrial Cancer, Recurrent Endometrial Cancer, TP53 | Phase 2 | 2024-09-25 |
| Active Not Recruiting | PRISM for Depression and Anxiety in Young Adults With Cancer Cancer Diagnosis, Non-Metastatic Neoplasm, Anxiety | N/A | 2024-09-06 |
| Recruiting | The COMPASSION Study Breast Cancer, Metastatic Breast Cancer, Advanced Breast Cancer | N/A | 2024-09-01 |
| Withdrawn | PediCARE Health Equity Intervention in High-Risk Neuroblastoma Neuroblastoma, High-risk Neuroblastoma, Pediatric Cancer | N/A | 2024-09-01 |
| Recruiting | Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma Renal Carcinoma, Renal Cell Carcinoma, Urothelial Carcinoma | EARLY_Phase 1 | 2024-08-28 |
| Recruiting | Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-neg Breast Cancer, PALB2-Mutated Breast Carcinoma, HER2-negative Breast Cancer | Phase 1 | 2024-08-13 |
| Recruiting | The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer Breast Cancer Female, Breast Cancer, Breast Cancer Metastatic | Phase 2 | 2024-08-08 |
| Recruiting | Developing Restful Environments and Management Strategies for Pediatric Stem Cell Transplant Patients Stem Cell Transplant Complications, Sleep Disturbance | N/A | 2024-08-06 |
| Withdrawn | MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies Myeloid Malignancy, Myeloid Malignancies, Blood Cancer | N/A | 2024-07-29 |
| Recruiting | Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAG Colorectal Cancer, Metastatic Colon Cancer, Metastatic Colorectal Cancer | N/A | 2024-07-22 |
| Recruiting | BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP) Bronchiolitis Obliterans Syndrome, Bronchiolitis Obliterans, Lung Diseases | Phase 2 | 2024-05-31 |
| Active Not Recruiting | LuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancer Prostate Cancer, Metastatic Prostate Cancer, Metastatic Castration-resistant Prostate Cancer | Phase 1 | 2024-05-22 |
| Recruiting | PediRISE Feasibility Pediatric Cancer, Financial Stress, Financial Hardship | N/A | 2024-05-15 |
| Withdrawn | Cardiotoxicities in Patients Receiving BTKi Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | — | 2024-05-01 |
| Recruiting | Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D) Breast Cancer, Breast Cancer Female | N/A | 2024-03-28 |
| Recruiting | Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessmen Bladder Cancer, Metastatic Bladder Cancer, Unresectable Bladder Carcinoma | — | 2024-03-05 |
| Withdrawn | Marizomib Central Nervous System (CNS) Multiple Myeloma, Multiple Myeloma in Relapse, Multiple Myeloma, Refractory | Phase 2 | 2024-03-01 |
| Recruiting | CIML NK Cells With Venetoclax for AML Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Leukemia | Phase 1 | 2024-02-20 |
| Completed | INTENT Pilot Study - Enhancing Adherence Intentions to Endocrine Therapy Breast Cancer, Breast Cancer Female, Breast Carcinoma | N/A | 2024-02-15 |
| Recruiting | RecoverPC: Relugolix vs GnRH Agonist in Quality of Life Prostate Cancer, Prostatic Neoplasms | Phase 2 | 2024-02-12 |
| Recruiting | Preliminary Efficacy of Different Exercise Training During Immunotherapy in Patients With Lung Cancer: The ENH Lung Cancer | N/A | 2024-02-01 |
| Recruiting | Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation Acute Myeloid Leukemia, Leukemia, Leukemia, Myeloid | Phase 1 | 2024-01-24 |
| Recruiting | CV CARE: CardioVascular Care in PC Patients Prostate Cancer, Cardiovascular Diseases | N/A | 2024-01-18 |
| Active Not Recruiting | Exercise for Tumor Suppressive Impact in Black Men With Prostate Cancer on Active Surveillance: The REMOVE Tri Prostate Cancer, Prostatic Neoplasms | N/A | 2024-01-01 |
| Recruiting | Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIER PROSTATE CANCER, Metastatic Prostate Cancer, Metastatic Prostate Carcinoma | N/A | 2024-01-01 |
| Recruiting | High-Intensity Interval Exercise in Young Adult Survivors of Pediatric Brain Tumors: A Pilot Feasibility Study Pediatric Brain Tumor | N/A | 2023-12-04 |
| Recruiting | Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC | EARLY_Phase 1 | 2023-11-21 |
| Recruiting | Promoting Resilience in Early Survivorship Among Adolescents and Young Adults With Cancer Stress, Anxiety | N/A | 2023-10-16 |
| Active Not Recruiting | TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma | Phase 2 | 2023-10-05 |
| Completed | Insomnia Prevention in Children With Acute Lymphoblastic Leukemia Pediatric Acute Lymphoblastic Leukemia, Leukemia, Acute Lymphoblastic Leukemia | N/A | 2023-09-26 |
| Recruiting | A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest Urologic Cancer, Urologic Neoplasms, Bladder Cancer | N/A | 2023-08-30 |
| Recruiting | Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation Multiple Myeloma, Stem Cell Transplant Complications | N/A | 2023-06-29 |
| Recruiting | Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC Head and Neck Squamous Cell Carcinoma, Head and Neck Cancer, Resectable Head and Neck Squamous Cell Carcinoma | Phase 2 | 2023-05-20 |
| Recruiting | Pirtobrutinib and Venetoclax in Waldenström Macroglobulinemia Waldenstrom Macroglobulinemia | Phase 2 | 2023-05-02 |
| Withdrawn | Implantable Microdevice for TNBC - Pilot Study Triple Negative Breast Cancer, Breast Cancer Stage II, Breast Cancer Stage III | Phase 1 | 2023-05-01 |
| Recruiting | Enhancing Information Management for Young Adults After Genetic Cancer Risk Testing Genetic Predisposition to Disease, Genetic Predisposition | N/A | 2023-05-01 |
| Recruiting | InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer Cancer Risk, Cancer Predisposition Syndrome, Hereditary Cancer Prediction | — | 2023-04-25 |
| Active Not Recruiting | STOP-HER2: Stopping Trastuzumab in HER2+ MBC Breast Cancer, Metastatic Breast Cancer, HER2-positive Breast Cancer | Phase 2 | 2023-04-19 |
| Active Not Recruiting | CAR- PRISM (PRecision Intervention Smoldering Myeloma) Multiple Myeloma, Smoldering Multiple Myeloma | Phase 2 | 2023-04-19 |
| Recruiting | TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Pat Breast Cancer, Stage III Breast Cancer, Breast Cancer Female | N/A | 2023-03-20 |
| Completed | Sleep Treatment Education Program-1 (STEP-1) Cancer Survivors, Insomnia | N/A | 2023-03-10 |
| Completed | PROFAST Intervention in Precursor Multiple Myeloma Cancer Prevention, Weight Loss, Smoldering Waldenstrom Macroglobulinemia(WM) | N/A | 2023-03-06 |
| Recruiting | A Novel Intervention for Patients With Cancer Substance Use, Cancer, Psychological | N/A | 2023-03-01 |
| Recruiting | Patient-Centered Surgical Prehabilitation Bladder Cancer, Cystectomy | N/A | 2023-03-01 |
| Completed | Deep Clinical Trajectory Modeling to Optimize Accrual to Cancer Clinical Trials Cancer | N/A | 2023-01-30 |
| Recruiting | Biology of Young Lung Cancer Study: The YOUNG LUNG Study Non Small Cell Lung Cancer, Small Cell Lung Carcinoma, NUT Carcinoma | — | 2023-01-01 |
| Recruiting | Investigating Hereditary Risk In Thoracic Cancers (INHERIT) Lung Cancer, Genetic Disease, Genetic Predisposition | — | 2023-01-01 |
| Completed | Development and Piloting an Avatar-based Intervention to Support Patients Undergoing Stem Cell Transplantation Hematopoietic Cell Transplantation | N/A | 2022-12-06 |
| Completed | The SPOT-HPV Study HPV Infection, HPV Positive Oropharyngeal Squamous Cell Carcinoma | — | 2022-11-30 |
| Active Not Recruiting | Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC) Breast Cancer, Gastrointestinal Cancer, Gynecologic Cancer | N/A | 2022-11-28 |
| Completed | Sleep Treatment Education Program for Young Adult Cancer Survivors (STEP-YA) Insomnia, Insomnia Due to Medical Condition, Cancer | N/A | 2022-11-19 |
| Active Not Recruiting | Testing Home-based Exercise Strategies in Underserved Minority Cancer Patients Undergoing Chemotherapy: the TH Breast Cancer, Colorectal Cancer, Prostate Cancer | N/A | 2022-10-31 |
| Withdrawn | Olaparib in Unresectable/Metastatic Melanoma With BRCA1/2 Recurrent Metastatic Melanoma, Cutaneous Melanoma, Mucosal Melanoma | Phase 2 | 2022-10-04 |
| Completed | Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture (PACT Trial) Acupuncture, Early-stage Breast Cancer, Chemotherapy-induced Peripheral Neuropathy | N/A | 2022-09-08 |
| Recruiting | Resistance Exercise Combined With Protein Supplementation in People With Pancreatic Cancer: The RE-BUILD Trial Pancreatic Cancer | N/A | 2022-09-01 |
| Withdrawn | SIGNAL:Identifying Behavioral Anomalies Using Smartphones to Improve Cancer Care Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma | N/A | 2022-09-01 |
| Recruiting | Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Thera Androgen Deprivation Therapy, Prostate Cancer, Prostate Cancer Metastatic | N/A | 2022-08-11 |
| Recruiting | Video Education With Result Dependent dIsclosure Genetic Testing, Breast Cancer, Ovarian Cancer | N/A | 2022-08-04 |
| Completed | STAMP+CBT mHealth for Cancer Pain Active Cancer, Active Cancer Treatment, Advanced Cancer | N/A | 2022-07-01 |
| Withdrawn | GROW (Glioma Specialists Reaching Out With Support) Support Low-grade Glioma, Survivorship, Care Giving Burden | N/A | 2022-07-01 |
| Recruiting | Intraoral Photobiomodulation Therapy to Prevent Oral Mucositis in Patients Undergoing Hematopoietic Cell Trans Myeloablative Allogeneic Hematopoietic Cell Transplantation, Intraoral Photobiomodulation Therapy, Oral Mucositis | N/A | 2022-06-10 |
| Completed | Early Interventional Treatment for Cancer Pain Cancer Pain | N/A | 2022-06-02 |
| Recruiting | Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial Graft Vs Host Disease, Acute-graft-versus-host Disease, Chronic Graft-versus-host-disease | N/A | 2022-04-14 |
| Recruiting | Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Ovarian Cancer, Ovarian Carcinoma, Ovarian Cancer Stage IV | N/A | 2022-04-02 |
| Unknown | Urologic Lymphadenectomy in AMIGO Urologic Cancer, Lymph Node Metastasis | N/A | 2022-04-01 |
| Active Not Recruiting | Personalized Neoantigen Cancer Vaccine + Pembrolizumab After Rituximab for Follicular Lymphoma Follicular Lymphoma | Phase 1 | 2022-03-14 |
| Completed | ASP8374 + Cemiplimab in Recurrent Glioma Glioblastoma, Recurrent Glioblastoma | Phase 1 | 2022-03-09 |
| Recruiting | Zanubrutinib and Venetoclax in CLL (ZANU-VEN) Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) | Phase 2 | 2022-02-18 |
| Recruiting | UPLYFT For Lymphoma Survivors Lymphoma, Survivorship | N/A | 2022-02-08 |
| Active Not Recruiting | RCT of CBD for Anxiety in Advanced Breast Cancer Advanced Breast Cancer, Anxiety, CBD | Phase 2 | 2022-01-19 |
| Recruiting | Resilience and Equity in Aging, Cancer, and Health (REACH) Gastric Cancer, Colon Cancer, Esophageal Cancer | N/A | 2022-01-18 |
| Active Not Recruiting | NeoVax + CDX-301 and Nivolumab or Pembrolizumab in Melanoma Melanoma, Metastatic Melanoma | Phase 1 | 2022-01-03 |
| Terminated | Axillary Lymph Node Tattoo Marking Study Breast Cancer, Lymph Node Metastases | N/A | 2021-12-29 |
| Recruiting | Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOL Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma | N/A | 2021-12-27 |
| Withdrawn | Abemaciclib + Pembrolizumab In Glioblastoma Glioblastoma | Phase 2 | 2021-12-01 |
| Active Not Recruiting | The Effect of Yoga on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy) Chemotherapy-induced Peripheral Neuropathy, Nerve Pain, Neuropathy | N/A | 2021-10-29 |
| Recruiting | Scalp Cooling in MBC Metastatic Breast Cancer, Chemotherapy-induced Alopecia | Phase 2 | 2021-10-07 |
| Active Not Recruiting | Venetoclax Plus Inotuzumab for B-ALL B-cell Acute Lymphoblastic Leukemia, B-Cell Lymphoma, ALL | Phase 1 | 2021-09-24 |
| Completed | Move Together Boston Feasibility Pilot (Sit Less, Move More App for Black Breast Cancer Survivors & At-Risk Re Breast Cancer Survivor, Breast Cancer, Fitness Trackers | N/A | 2021-09-10 |
| Active Not Recruiting | Copanlisib Plus Venetoclax in R/R DLBCL Diffuse Large B Cell Lymphoma, Relapsed Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma | Phase 1 / Phase 2 | 2021-09-08 |
| Recruiting | Geriatric Thoracic Surgery Ambulation Challenge Thoracic Diseases, Surgery, Therapy, Exercise | N/A | 2021-08-25 |
| Active Not Recruiting | Acalabrutinib in CNSL Central Nervous System Lymphoma, Refractory Central Nervous System Lymphoma, Recurrent Central Nervous System Lymphoma | Phase 1 / Phase 2 | 2021-08-23 |
| Active Not Recruiting | Abemaciclib With or Without Atezolizumab for mCRPC Prostate Cancer, Metastatic Castration-resistant Prostate Cancer | Phase 2 | 2021-08-20 |
| Recruiting | A Personalized Neoantigen Cancer Vaccine in Treatment Naïve, Asymptomatic Patients With IGHV Unmutated CLL. Lymphocytic Leukemia | Phase 1 | 2021-08-18 |
| Active Not Recruiting | Taking AIM at Breast Cancer Breast Cancer, Breast Cancer Stage I, Breast Cancer Stage II | N/A | 2021-08-13 |
| Active Not Recruiting | Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical Activity Breast Cancer, Coronary Artery Disease, Stroke | N/A | 2021-08-12 |
| Completed | TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance) Breast Cancer, Prostate Cancer, Patient Engagement | N/A | 2021-08-01 |
| Recruiting | Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or E Endometrial Carcinoma, Obesity, EIN | N/A | 2021-08-01 |
| Completed | Intravenous Magnesium in Patients Receiving Cisplatin Mesothelioma | Phase 1 | 2021-07-30 |
| Completed | Feasibility Pilot Exploring Variability in Biomarkers and PROs in AML Acute Myeloid Leukemia (AML) | — | 2021-07-26 |
| Recruiting | Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing Che Breast Cancer, Chemotherapy Effect, Exercise Therapy | N/A | 2021-07-14 |
| Completed | My Mindful Moments: A Mindfulness Meditation and Digital Art Activity Mindfulness, Meditation | N/A | 2021-07-01 |
| Terminated | Troriluzole or Placebo Plus Ipi Plus Nivo in Mel Brain Mets Melanoma, Metastatic Melanoma | Phase 2 | 2021-06-30 |
| Active Not Recruiting | Phase Ia/Ib Talazoparib + Tazemetostat for mCRPC Metastatic Prostate Cancer, Metastatic Castration-resistant Prostate Cancer | Phase 1 | 2021-06-28 |
| Recruiting | ATEMPT 2.0: Adjuvant T-DM1 vs TH Breast Cancer, HER2-positive Breast Cancer | Phase 2 | 2021-06-16 |
| Recruiting | Protocol For Genomically Profiling, Collecting, Archiving And Distributing Blood And Bone Marrow Specimens Fro Leukemia, Myelodysplastic Syndromes, Myeloproliferative Syndrome | — | 2021-06-11 |
| Withdrawn | Dilute Bleach Compresses for Radiation Dermatitis Radiation Dermatitis | EARLY_Phase 1 | 2021-06-09 |
| Active Not Recruiting | Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL Hodgkin Lymphoma, Relapsed Hodgkin's Disease, Adult, Refractory Hodgkin Lymphoma | Phase 2 | 2021-06-04 |
| Recruiting | Refining Local-Regional Therapy for IBC Breast Cancer, Inflammatory Breast Cancer, Sentinel Lymph Node | N/A | 2021-06-02 |
| Recruiting | Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer Non-small Cell Lung Cancer, Advanced Pancreatic Adenocarcinoma, Unresectable Pancreatic Cancer | Phase 1 / Phase 2 | 2021-05-27 |
| Completed | Survivor-Sleep Health Information Program Sleep Problem, Insomnia, Pediatric Cancer | N/A | 2021-05-24 |
| Active Not Recruiting | The Effect of Electroacupuncture on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropa Chemotherapy-induced Peripheral Neuropathy, Nerve Pain, Neuropathy | N/A | 2021-05-21 |
| Recruiting | Sacituzumab Govitecan Plus EV in Metastatic UC Urothelial Cancer, Metastatic Urothelial Carcinoma, Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter | Phase 1 / Phase 2 | 2021-05-20 |
| Completed | Routine Evaluation of the Social Determinants of Health in Oncology: User-centered Resource Coordination and E Breast Cancer, Lung Cancer, Gastrointestinal Cancer | N/A | 2021-05-17 |
| Active Not Recruiting | Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma | Phase 2 | 2021-04-27 |
| Withdrawn | Sargramostim (GM-CSF) + PD-1 Unresectable Melanoma, Metastatic Melanoma, Stage III Melanoma | Phase 2 | 2021-04-16 |
| Active Not Recruiting | Safe Accelerated Venetoclax Escalation in CLL Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 1 | 2021-04-14 |
| Completed | AWARENESS Trial (AWARENESS) of Storytelling Through Music in Healthcare Workers Stress, Post Traumatic Stress Disorder, Work Related Stress | N/A | 2021-03-01 |
| Active Not Recruiting | Intervention For AYAS With Cancer Risk Syndromes Cancer Risk Syndrome | N/A | 2021-03-01 |
| Active Not Recruiting | Digitally Enhanced Smoking Cessation for High Risk Smokers Smoking, Smoking Cessation, Lung Cancer Screening | N/A | 2021-02-01 |
| Completed | Step Into Support for Endurance and Strength (SISTERS) Gynecologic Cancer | N/A | 2021-01-29 |
| Completed | Feasibility of Fasting & Exercise in Pts With HR+ MBC Breast Cancer, Metastatic Breast Cancer | N/A | 2021-01-15 |
| Recruiting | IS-free Treg HaploHCT Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute | Phase 1 | 2021-01-12 |
| Active Not Recruiting | A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anato HER2-positive Breast Cancer, Invasive Carcinoma of the Breast, Breast Cancer | Phase 2 | 2021-01-11 |
| Completed | ABEMA Alone or in COMBO With MK-6482 Clear Cell Renal Cell Carcinoma | Phase 1 | 2020-12-31 |
| Recruiting | Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas Salivary Gland Cancer, HER2 Gene Mutation | Phase 2 | 2020-12-24 |
| Completed | Cabozantinib With Topotecan-Cyclophosphamide Relapsed Ewing Sarcoma, Refractory Ewing Sarcoma, Relapsed Osteosarcoma | Phase 1 | 2020-12-23 |
| Active Not Recruiting | Niraparib + Dostarlimab In BRCA Mutated Breast Cancer Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer | Phase 2 | 2020-12-18 |
| Completed | Advance Care Planning: Communicating With Outpatients for Vital Informed Decision Advanced Care Planning, Shared Decision Making, Video Decision Aids | — | 2020-12-15 |
| Active Not Recruiting | Axi-cel in CNS Lymphoma Lymphoma, Lymphoma Cns | Phase 1 | 2020-12-04 |
| Completed | REVITALIZE: A Telehealth Intervention for Women With Advanced Ovarian Cancer and PARP Inhibitor-Related Fatigu Ovarian Cancer, Fatigue, Coping Behavior | N/A | 2020-12-02 |
| Completed | RESIST-ADT (Androgen Deprivation Therapy) Prostate Cancer, Physical Function | N/A | 2020-12-01 |
| Completed | Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers Breast Cancer, Ovarian Cancer, Pancreatic Cancer | N/A | 2020-12-01 |
| Active Not Recruiting | Olaparib With Ceralasertib in Recurrent Osteosarcoma Osteosarcoma, Osteosarcoma Recurrent | Phase 2 | 2020-11-24 |
| Active Not Recruiting | NeoVax With Nivolumab in Patients With Ovarian Cancer Ovarian Cancer | Phase 1 | 2020-11-20 |
| Active Not Recruiting | Post-treatment Surveillance in HPV+ Oropharyngeal SCC HPV, Oropharyngeal Squamous Cell Carcinoma | — | 2020-11-19 |
| Active Not Recruiting | Neoantigen Vaccine Plus Locally Administered Ipilimumab and Systemic Nivolumab in Advanced Melanoma Cutaneous Melanoma | Phase 1 | 2020-11-11 |
| Completed | Effect of Perampanel on Peritumoral Hyperexcitability in HGG Glioma, Malignant, Surgery, Seizures | Phase 1 / Phase 2 | 2020-11-05 |
| Completed | Cemiplimab in AlloSCT/SOT Recipients With CSCC Cutaneous Squamous Cell Carcinoma, Advanced Cancer | Phase 1 / Phase 2 | 2020-11-03 |
| Completed | Preventative Skin Care for Children Undergoing Targeted CNS Tumor Therapy Pediatric Cancer, CNS Tumor, Childhood, Skin Inflammation | Phase 2 | 2020-10-01 |
| Active Not Recruiting | YES Study - Newly Diagnosed/Metastatic Intervention Breast Cancer, Symptom, Behavioral | N/A | 2020-09-16 |
| Recruiting | Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress Li-Fraumeni Syndrome, TP53 Gene Mutation, Hereditary Cancer Syndrome | — | 2020-09-15 |
| Active Not Recruiting | Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers Malignant Rhabdoid Tumor, Rhabdoid Tumor of the Kidney, Epithelioid Sarcoma | Phase 2 | 2020-08-14 |
| Terminated | Phase I Study of Marizomib + Panobinostat for Children With DIPG Diffuse Intrinsic Pontine Glioma, Pediatric Brainstem Glioma, Pediatric Brainstem Gliosarcoma, Recurrent | Phase 1 | 2020-08-10 |
| Recruiting | Pembrolizumab, Ibrutinib and Rituximab in PCNSL Primary Central Nervous System Lymphoma, Recurrent Cancer, Refractory Cancer | Phase 1 / Phase 2 | 2020-08-01 |
| Terminated | VB-111 in Surgically Accessible Recurrent/Progressive GBM Glioblastoma, Recurrent Glioblastoma | Phase 2 | 2020-08-01 |
| Completed | CIML NK Cell in Head & Neck Cancer Squamous Cell Carcinoma of the Head and Neck, Recurrent Head and Neck Squamous Cell Carcinoma | Phase 1 | 2020-07-20 |
| Recruiting | Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC Breast Cancer, Triple Negative Breast Cancer, PD-L1 Negative | Phase 2 | 2020-07-20 |
| Completed | LY3214996 in Patients With AML Who Are Not Candidates for Standard Therapy Acute Myeloid Leukemia | Phase 1 | 2020-07-15 |
| Active Not Recruiting | MARGetuximab Or Trastuzumab (MARGOT) Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer | Phase 2 | 2020-07-13 |
| Active Not Recruiting | Ibrutinib + Venetoclax in Untreated WM Waldenstrom Macroglobulinemia, MYD88 Gene Mutation | Phase 2 | 2020-07-09 |
| Recruiting | Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA) Breast Cancer, Triple Negative Breast Cancer, Residual Cancer | Phase 2 | 2020-07-02 |
| Withdrawn | Tucatinib + Abemaciclib + Herceptin for HER2+ MBC Breast Cancer | Phase 1 | 2020-06-28 |
| Terminated | Conventional Androgen Deprivation Therapy (ADT) With or Without Abiraterone Acetate + Prednisone and Apalutami Prostate Cancer | Phase 3 | 2020-04-20 |
| Completed | Advance Care Planning: Promoting Effective and Aligned Communication in the Elderly Other Cancer | N/A | 2020-04-15 |
| Withdrawn | ERK 1/2 Signaling in Ibrutinib Resistant B-cell Malignancies Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia, Mantle Cell Lymphoma | Phase 1 | 2020-02-03 |
| Active Not Recruiting | Genetic Testing for All Breast Cancer Patients (GET FACTS) Breast Cancer, Invasive Breast Cancer, In Situ Breast Cancer | N/A | 2020-01-31 |
| Terminated | GVAX Plus Checkpoint Blockade in Neuroblastoma Neuroblastoma, Pediatric Solid Tumor | Phase 1 | 2020-01-29 |
| Terminated | Ex Vivo TCR αβ T Cell Depletion for Graft-Versus-Host Disease Prophylaxis in Mismatched Donor Peripheral Blood Hematologic Malignancy | Phase 2 | 2020-01-21 |
| Recruiting | Serial MRI Scans During Radiation Therapy Glioblastoma, Esophageal Cancer, Radiotherapy | N/A | 2020-01-15 |
| Active Not Recruiting | A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC) Endometrial Cancer | Phase 2 | 2020-01-02 |
| Terminated | Topical Tazarotene Vs Placebo In Hand-Foot-Skin Reactions Solid Tumor, Hand-Foot Skin Reaction (HFSR) | Phase 2 | 2019-12-30 |
| Completed | Cabozantinib and Nivolumab for Carcinoid Tumors Carcinoid Tumor, Carcinoid Tumor of GI System, Neuroendocrine Tumors | Phase 2 | 2019-12-26 |
| Completed | OPTimizing Treatment Focused Genetic Testing IN Cancer Breast Cancer, Ovarian Cancer, Pancreatic Cancer | N/A | 2019-12-19 |
| Completed | Videos for Advance Care Planning in Young Adults Advanced Cancer | N/A | 2019-12-13 |
| Recruiting | A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma Cutaneous T Cell Lymphoma, Peripheral T Cell Lymphoma | N/A | 2019-12-11 |
| Terminated | Palbociclib + Ganitumab In Ewing Sarcoma Ewing Sarcoma, Ewing's Sarcoma Recurrent | Phase 2 | 2019-12-05 |
| Withdrawn | Rogaratinib for BCG Refractory High Risk Non-Muscle Invasive Bladder Cancer With FGFR1/2 Overexpression Bladder Cancer | Phase 2 | 2019-11-27 |
| Completed | Smart Phone App Intervention In Young Adults With Cancer Cancer, Young Adults, Behavioral Intervention | N/A | 2019-11-11 |
| Recruiting | Stereotactic Magnetic Resonance Guided Radiation Therapy Pancreas Cancer, Lung Cancer, Renal Cancer | N/A | 2019-10-22 |
| Completed | Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatr Solid Tumor, Childhood, Lymphoma, Brain Tumor, Pediatric | Phase 1 | 2019-09-27 |
| Terminated | The Value of Advanced MR Imaging in Gynecological Tumors and Benign Uterine Fibroids Gynecologic Tumor | N/A | 2019-09-18 |
| Withdrawn | A Phase II Trial of Neoadjuvant Treatment With PD-1 Inhibition (Nivolumab) With or Without IDO Inhibition (BMS Melanoma Stage III, Melanoma Stage IV | Phase 2 | 2019-09-06 |
| Recruiting | A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation Acute Myeloid Leukemia, Myelodysplastic Syndromes, Myeloproliferative Neoplasm | Phase 1 | 2019-08-31 |
| Completed | Yoga for Painful Chemotherapy-Induced Peripheral Neuropathy: A Pilot, Randomized-Controlled Study Chemotherapy-induced Peripheral Neuropathy, Yoga, Chronic Pain | N/A | 2019-08-06 |
| Completed | A Trial of All-trans Retinoic Acid (ATRA) in Advanced Adenoid Cystic Carcinoma Adenoid Cystic Carcinoma | Phase 2 | 2019-08-05 |
| Active Not Recruiting | Talazoparib for Cohesin-Mutated AML and MDS With Excess Blasts Leukemia | Phase 1 | 2019-08-01 |
| Completed | Symptom Management Implementation of Patient Reported Outcomes in Oncology Other Cancer, Gastrointestinal Cancer, Thoracic Cancer | N/A | 2019-07-25 |
| Completed | Mobile Health App to Mitigate the Metabolic Effects of Androgen Deprivation Therapy Prostate Cancer | N/A | 2019-07-16 |
| Active Not Recruiting | A Pilot Study of Quantitative Tumor Oxygen Measurements in Cervical Cancer Gynecologic Cancer, Cervical Cancer | — | 2019-07-16 |
| Active Not Recruiting | A Phase 1 Trial of CD25/Treg-depleted DLI Plus Ipilimumab for Myeloid Disease Relapse After Matched-HCT Acute Myeloid Leukemia, Myelodysplastic Syndromes, Myeloproliferative Neoplasms | Phase 1 | 2019-07-10 |
| Completed | Induction TPN Followed by Nivolumab With Radiation in Locoregionally Advanced Laryngeal and Hypopharyngeal Can Head and Neck Cancer | Phase 2 | 2019-06-11 |
| Completed | A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas Sarcoma, Liposarcoma, Leiomyosarcoma | Phase 2 | 2019-06-04 |
| Completed | Pilot Feasibility of the Pediatric Cancer Resource Equity (PediCARE) Intervention Other Cancer | N/A | 2019-05-28 |
| Completed | Young, Empowered & Strong (YES): The Young Women's Breast Cancer Study 2- Focus on Intervention Pilot Breast Cancer | N/A | 2019-05-23 |
| Recruiting | Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcino Head and Neck Cancer | N/A | 2019-05-20 |
| Completed | Individualizing Surveillance Mammography for Older Breast Cancer Survivors Breast Cancer | N/A | 2019-05-16 |
| Active Not Recruiting | GENetic Education Risk Assessment and TEsting Study Candidates for Hereditary Pancreatic Cancer Testing | N/A | 2019-05-08 |
| Completed | The PRISM Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults With Advance Cancer, Quality of Life, Anxiety | N/A | 2019-04-15 |
| Active Not Recruiting | 'ADVANCE' (A Pilot Trial) Breast Cancer | Phase 1 | 2019-03-21 |
| Active Not Recruiting | Prospective Study of the Prosigna Assay on Neoadjuvant Clinical Decision-making in Women With HR+/Her2- Breast Breast Cancer | — | 2019-03-21 |
| Completed | Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency Prostate Cancer | Phase 2 | 2019-03-19 |
| Completed | EHR-embedded OCDT in Breast or GI Cancer Oral Cancer Directed Therapy, Breast Cancer, Gastrointestinal Cancer | N/A | 2019-03-13 |
| Active Not Recruiting | NIMBUS: Nivolumab Plus Ipilimumab in Metastatic Hypermutated HER2-negative Breast Cancer Breast Cancer | Phase 2 | 2019-03-08 |
| Completed | Acceptance and Commitment Therapy (ACT) - Based Treatment Development for Cancer Patients Treated for Pain Cancer | — | 2019-02-20 |
| Completed | A Feasibility Study of Durvalumab +/- Oleclumab as Neoadjuvant Therapy for Muscle-invasive Bladder Cancer (BLA Muscle Invasive Bladder Cancer | Phase 1 | 2019-02-20 |
| Active Not Recruiting | Elevate! : An Elderly Breast Cancer Cohort Study Breast Cancer | — | 2019-02-19 |
| Terminated | GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases Breast Cancer | Phase 2 | 2019-02-11 |
| Active Not Recruiting | Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL Acute Lymphoblastic Leukemia ALL | Phase 1 | 2019-01-30 |
| Completed | Mindfulness-Music Intervention for Adolescents and Young Adults With Cancer Anxiety, Oncology, Stress | N/A | 2019-01-22 |
| Terminated | Prexasertib in Combination With MEC in Relapsed/Refractory AML and High Risk MDS - a Phase I Trial Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 1 | 2019-01-18 |
| Completed | Acupuncture for Hot Flashes in Hormone Receptor-Positive Breast Cancer, a Randomized Controlled Trial Breast Cancer | N/A | 2019-01-15 |
| Recruiting | RESOLVE: Abemaciclib + Letrozole +/- Metformin, Zotatifin, or Gedatolisib in Endometrial or Low-Grade Serous O Endometrial Cancer, Ovarian Cancer | Phase 2 | 2018-12-24 |
| Terminated | Avelumab and Radiation in Muscle-Invasive Bladder Cancer Bladder Cancer, Muscle Invasive Bladder Cancer | Phase 2 | 2018-12-13 |
| Completed | Safety and Efficacy of Nivolumab in Treating Oral Proliferative Verrucous Leukoplakia Leukoplakia, Oral | Phase 2 | 2018-12-05 |
| Terminated | Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic Cancer Pancreatic Cancer | Phase 1 | 2018-12-05 |
| Withdrawn | An Exploratory Study to Evaluate the Combination of Elotuzumab and Nivolumab With and Without Pomalidomide in Multiple Myeloma | Phase 2 | 2018-12-01 |
| Completed | Sexual Health and Rehabilitation After Ovarian Suppression Treatment Breast Cancer Survivors, Sexual Function Disturbances, Ovarian Suppression Treatment | N/A | 2018-12-01 |
| Completed | Testing Feasibility of Motivational Interviewing for Patient-Reported Cancer Pain Goals Other Cancer | N/A | 2018-11-16 |
| Completed | Mathematical Model-Adapted Radiation In Glioblastoma Recurrent Glioblastoma | N/A | 2018-11-12 |
| Active Not Recruiting | DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC Breast Cancer | Phase 1 | 2018-11-05 |
| Completed | Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer Leukemia, Brain Tumor, Solid Tumor | Phase 1 | 2018-11-01 |
| Completed | Smartphone Technology to Alleviate Malignant Pain (STAMP) Cancer, Pain Management, Opioid Use | N/A | 2018-11-01 |
| Recruiting | Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE) Multiple Myeloma | — | 2018-10-31 |
| Recruiting | Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarker Mesothelioma | N/A | 2018-10-31 |
| Terminated | Rituximab + Immunotherapy in Follicular Lymphoma Follicular Lymphoma | Phase 1 | 2018-10-30 |
| Active Not Recruiting | AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma Uterine Cancer | Phase 2 | 2018-10-22 |
| Active Not Recruiting | Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naïve AML Acute Myeloid Leukemia | Phase 1 | 2018-10-17 |
| Completed | Peri-Transfusion QOL Assessments (PTQA): A New Paradigm of Transfusion Decision Support for Patients With MDS Myelodysplastic Syndromes | N/A | 2018-10-17 |
| Active Not Recruiting | Olaparib + Sapacitabine in BRCA Mutant Breast Cancer Breast Cancer | Phase 1 | 2018-10-01 |
| Completed | Pembrolizumab and Reirradiation in Bevacizumab Naïve and Bevacizumab Resistant Recurrent Glioblastoma Glioblastoma | Phase 2 | 2018-09-28 |
| Active Not Recruiting | Physical Activity, Proliferation and Immune Markers in Benign Breast Tissue Breast Cancer | N/A | 2018-09-17 |
| Completed | MCS110 With BRAF/MEK Inhibition in Patients With Melanoma Melanoma | Phase 1 / Phase 2 | 2018-09-10 |
| Completed | EL CENTRO: Engaging Latinos in the Center of Cancer Treatment Options Metastatic Pancreatic Cancer, Unresectable Pancreatic Cancer, Metastatic Colorectal Cancer | N/A | 2018-09-01 |
| Completed | Study of Venetoclax, a BCL2 Antagonist, for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Blastic Plasmacytoid Dendritic Cell Neoplasm | Phase 1 | 2018-08-23 |
| Completed | Niraparib in Patients With Pancreatic Cancer Pancreatic Cancer | Phase 2 | 2018-08-22 |
| Active Not Recruiting | ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer Breast Cancer | Phase 2 | 2018-08-22 |
| Recruiting | Osimertinib In EGFR Mutant Lung Cancer Carcinoma, Non-Small-Cell Lung | Phase 2 | 2018-08-13 |
| Completed | Web-based Insomnia Treatment for Adolescent and Young Adult Cancer Survivors Insomnia | N/A | 2018-08-10 |
| Active Not Recruiting | Acalabrutinib, Venetoclax, and Obinutuzumab for Initial Therapy of CLL Chronic Lymphocytic Leukemia (CLL) | Phase 2 | 2018-08-07 |
| Completed | Prospective Study of BK Virus Disease After Allogeneic Hematopoietic-cell Transplantation: Defining BK Disease BK Virus Infection | — | 2018-07-30 |
| Completed | SHARE (Sharing Goals and Preferences) Study Other Cancer | N/A | 2018-07-23 |
| Completed | Stepping Into Survivorship: Harnessing Behavioral Economics to Improve Quality of Life in Ovarian Cancer Ovarian Cancer | N/A | 2018-07-20 |
| Active Not Recruiting | Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS Chronic Lymphocytic Leukemia, Richter Syndrome | Phase 1 / Phase 2 | 2018-07-12 |
| Completed | The GI Binder: A Psychoeducational Intervention for Gastrointestinal Cancer Patients Gastro Intestinal Cancer | N/A | 2018-07-09 |
| Completed | Clinician Decision Support Algorithm for Chemotherapy-Induced Peripheral Neuropathy Cancer, Chemotherapy-induced Peripheral Neuropathy | N/A | 2018-06-04 |
| Terminated | Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer Recurrent Gynecological Cancer, Metastatic Cervical Cancer, Metastatic Ovarian Cancer | Phase 1 | 2018-06-01 |
| Completed | A Study of Prexasertib (LY2606368), CHK1 Inhibitor, and LY3300054, PD-L1 Inhibitor, in Patients With Advanced Cancer | Phase 1 | 2018-05-16 |
| Terminated | Role of Contrast Enhanced Spectral Mammography to Predict Upgrade Rates of Biopsy Proven Atypical Ductal Hyper Atypical Ductal Hyperplasia | N/A | 2018-05-10 |
| Recruiting | Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD Ewing Sarcoma, Ewing Sarcoma of Bone, Ewing Sarcoma of Soft Tissue | N/A | 2018-05-08 |
| Completed | Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor Advanced Solid Tumor | Phase 1 | 2018-05-01 |
| Active Not Recruiting | Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis Breast Cancer | Phase 2 | 2018-05-01 |
| Completed | BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and Renewal Gynecologic Cancer, Gastrointestinal Cancer | N/A | 2018-04-24 |
| Terminated | Study of Pancreatic Enzyme Replacement on Completion of Adjuvant Chemotherapy for Resected Pancreatic Adenocar Pancreatic Cancer | Phase 2 | 2018-04-13 |
| Terminated | Biomarkers of Response to Ipilimumab and Nivolumab in First-line NSCLC Non-small Cell Lung Cancer | Phase 2 | 2018-04-10 |
| Active Not Recruiting | Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Breast Cancer | N/A | 2018-04-01 |
| Terminated | A Phase II Study of BVD-523 in Metastatic Uveal Melanoma Uveal Melanoma | Phase 2 | 2018-03-26 |
| Active Not Recruiting | Neodjuvant Nivolumab and Lirilumab, Followed by Surgery, Followed by Adjuvant Nivolumab and Lirilumab, in SCCH Squamous Cell Carcinoma of the Head and Neck | Phase 2 | 2018-03-15 |
| Completed | Understanding Barriers to Initiation and Adherence to Endocrine Therapy in Young Breast Cancer Survivors of Di Breast Cancer | — | 2018-03-09 |
| Terminated | Ivabradine in the Management of Cardiac Autonomic Dysfunction Associated With Thoracic Radiation Therapy. Lymphoma, Autonomic Imbalance, Cancer Survivorship | Phase 2 | 2018-02-27 |
| Active Not Recruiting | Stereotactic Radiation in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases Brain Metastases, Small Cell Lung Cancer | N/A | 2018-02-23 |
| Active Not Recruiting | A Phase 2 Study of Osimertinib in Combination With Selumetinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lu Non-small Cell Lung Cancer | Phase 2 | 2018-01-31 |
| Active Not Recruiting | Carboplatin +/- Nivolumab in Metastatic Triple Negative Breast Cancer Breast Cancer | Phase 2 | 2018-01-30 |
| Completed | HealthSmart: Promoting Healthy Lifestyles for Young Adult Cancer Survivors Using Educational Videos Environmental Exposure to Ultraviolet Light | N/A | 2018-01-30 |
| Active Not Recruiting | Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cance Inflammatory Breast Cancer (IBC) | Phase 2 | 2018-01-24 |
| Completed | Study of Gemcitabine, Nab-paclitaxel, and Ficlatuzumab (AV-299) in Patients With Advanced Pancreatic Cancer Pancreatic Cancer | Phase 1 | 2018-01-17 |
| Completed | A Nurse Led Project to Introduce Hand Lettering as a Form of Creative Art Expression to Patients in an Ambulat Anxiety | N/A | 2018-01-09 |
| Completed | Shared Care: Patient-Centered Management After Hematopoietic Cell Transplantation Other Cancer | N/A | 2018-01-01 |
| Active Not Recruiting | Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors Genitourinary Cancer, Adrenocortical Carcinoma, Non-urothelial Bladder | Phase 2 | 2017-12-28 |
| Completed | Exercise Intervention Among Men With Prostate Cancer Initiating Androgen Deprivation Therapy Prostate Cancer | N/A | 2017-12-08 |
| Suspended | Pembrolizumab in Neoplasms or Lymphomas Lymphoma, Histiocytic Sarcoma, Follicular Dendritic Cell Sarcoma | Phase 2 | 2017-12-07 |
| Active Not Recruiting | PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions Breast Cancer | N/A | 2017-12-01 |
| Completed | Physical Activity In Gastrointestinal Cancer Metastatic Gastrointestinal Cancer, Physical Activity | N/A | 2017-12-01 |
| Completed | A Phase II Study of Nivolumab in Combination With Cabozantinib for Metastatic Triple-negative Breast Cancer Breast Cancer | Phase 2 | 2017-11-30 |
| Completed | A Study of Daratumumab in Patients With Relapsed or Refractory Waldenström Macroglobulinemia Waldenström Macroglobulinemia | Phase 2 | 2017-11-27 |
| Active Not Recruiting | Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multip Monoclonal Gammopathy, Smoldering Multiple Myeloma | Phase 2 | 2017-11-24 |
| Active Not Recruiting | Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMUL Prostate Cancer | Phase 2 | 2017-11-24 |
| Recruiting | Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Ty Cancer | Phase 2 | 2017-11-21 |
| Completed | Genetic Counseling Processes and Outcomes Among Males With Prostate Cancer (ProGen) Prostate Cancer | N/A | 2017-11-21 |
| Active Not Recruiting | Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer Gynecologic Cancer | N/A | 2017-11-13 |
| Terminated | Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer, HER2-Negative Breast Cancer, Metastatic Epithelial Ovarian Cancer | Phase 1 | 2017-11-08 |
| Recruiting | Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL Leukemia | Phase 1 / Phase 2 | 2017-10-30 |
| Terminated | Neratinib +/- Fulvestrant in HER2+, ER+ Metastatic Breast Cancer Breast Cancer | Phase 2 | 2017-10-25 |
| Terminated | A Study of Ulocuplumab And Ibrutinib in Symptomatic Patients With Mutated CXCR4 Waldenstrom's Macroglobulinemi Waldenstrom's Macroglobulinemia | Phase 1 | 2017-10-20 |
| Completed | Nivolumab Plus Ipilimumab in Thyroid Cancer Thyroid Cancer | Phase 2 | 2017-10-03 |
| Active Not Recruiting | Palbociclib After CDK and Endocrine Therapy (PACE) Metastatic Breast Cancer | Phase 2 | 2017-09-05 |
| Completed | Post-Operative Ambulatory Challenge and Exercise (PACE) Trial Cancer | N/A | 2017-08-02 |
| Terminated | Cyclophosphamide and Alemtuzumab In Lymphoma Non Hodgkin Lymphoma, High-grade B-cell Lymphoma, Diffuse Large B Cell Lymphoma | Phase 1 | 2017-07-30 |
| Active Not Recruiting | A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2 Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma | Phase 1 | 2017-07-18 |
| Active Not Recruiting | Targeting PD-1 Therapy Resistance With Focused High or High and Low Dose Radiation in SCCHN Head and Neck Cancer | Phase 2 | 2017-06-30 |
| Recruiting | SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk My Acute Myeloid Leukemia, Myelodysplastic Syndrome, Blastic Plasmacytoid Dendritic Cell Neoplasm | Phase 1 | 2017-06-26 |
| Terminated | A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer Prostate Cancer | Phase 2 | 2017-06-23 |
| Completed | Ear Acupuncture During Chemotherapy Infusion for Breast Cancer, a Feasibility Study Breast Cancer | N/A | 2017-06-19 |
| Terminated | A Study of Alectinib in RET-rearranged Non-small Cell Lung Cancer or RET-mutated Thyroid Cancer ALK-positive Non-small Cell Lung Cancer (NSCLC), RET-positive Non-small Cell Lung Cancer (NSCLC), RET-positive Thyroid Cancer | Phase 1 / Phase 2 | 2017-06-19 |
| Completed | Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPC Prostate Cancer | Phase 2 | 2017-06-09 |
| Completed | LY3022855 With BRAF/MEK Inhibition in Patients With Melanoma Melanoma | Phase 1 / Phase 2 | 2017-06-06 |
| Completed | Study of Palbociclib in Combination With Binimetinib for Patients With Advanced KRAS Mutant Non-Small Cell Lun Lung Cancer | Phase 1 | 2017-05-31 |
| Terminated | Abemaciclib for Patients With Retinoblastoma-Positive, Triple Negative Metastatic Breast Cancer Breast Cancer | Phase 2 | 2017-05-26 |
| Terminated | Phase II PEMBROLIZUMAB + PALLIATIVE RADIOTHERAPY IN BC Metastatic Breast Cancer | Phase 2 | 2017-05-22 |
| Active Not Recruiting | Osimertinib and Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | 2017-05-09 |
| Completed | Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma Adenoid Cystic Carcinoma | Phase 2 | 2017-04-25 |
| Completed | The HOPE Trial and the SMART Study Gynecologic Cancer | N/A | 2017-04-12 |
| Active Not Recruiting | Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases Brain Metastases | N/A | 2017-04-10 |
| Terminated | A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma Mesothelioma | Phase 2 | 2017-04-10 |
| Completed | Qigong For PPSP In Breast Cancer Pain In Breast Cancer Survivors Breast Cancer Surgery Pain, Breast Cancer, Stage 0-III Breast Cancer | N/A | 2017-04-04 |
| Completed | Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer of Head and Neck, Cancer of Cervix, Cancer of Anus | Phase 1 / Phase 2 | 2017-03-30 |
| Completed | A Randomized Phase II Study Of Eribulin Mesylate With or Without Pembrolizumab For Metastatic Hormone Receptor Breast Cancer | Phase 2 | 2017-03-22 |
| Active Not Recruiting | A Phase II Study of Venetoclax in Combination With Dose-adjusted EPOCH-R or R-CHOP for Patients With Richter's Richter Syndrome | Phase 2 | 2017-03-08 |
| Completed | Reduction of Post Mastectomy Pain With the Jacki® Recovery Jacket Mastectomy | N/A | 2017-03-07 |
| Active Not Recruiting | Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents Acute Lymphoblastic Leukemia, Pediatric | Phase 3 | 2017-03-03 |
| Suspended | Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib Lung Cancer Squamous Cell, Solid Tumors, Head & Neck Cancer | Phase 1 | 2017-02-28 |
| Active Not Recruiting | Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy Pancreatic Cancer | — | 2017-02-24 |
| Completed | A Study Of Pembrolizumab In Combination With Trastuzumab-DM1 Breast Cancer | Phase 1 | 2017-02-17 |
| Completed | Improving Communication Between Cancer Patients & Oncologists Cancer | N/A | 2017-02-14 |
| Active Not Recruiting | A Study of Abemaciclib in Recurrent Glioblastoma Glioblastoma | Phase 2 | 2017-02-09 |
| Completed | CISPLATIN + AZD-1775 In Breast Cancer Triple-negative Metastatic Breast Cancer | Phase 2 | 2017-01-18 |
| Completed | Pembrolizumab in Refractory Advanced Esophageal Cancer Esophageal Cancer, Squamous Cell Esophagus Cancer, Adenocarcinoma Esophagus | Phase 2 | 2017-01-18 |
| Terminated | Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms T Ewing Sarcoma, Rhabdomyosarcoma, Wilms Tumor | Phase 1 / Phase 2 | 2017-01-01 |
| Active Not Recruiting | Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone Bone Cancer | Phase 2 | 2016-11-29 |
| Completed | Obinutuzumab in cGVHD After Allogeneic Peripheral Blood Stem Cell Transplantation Graft vs. Host Disease | Phase 2 | 2016-11-29 |
| Completed | Supine MRI in Breast Cancer Patients Undergoing Upfront Surgery or Receiving Neoadjuvant Therapy Breast Cancer | N/A | 2016-11-15 |
| Active Not Recruiting | Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelum Metastatic Endometrial Cancer | Phase 2 | 2016-11-14 |
| Terminated | Merestinib In Non-Small Cell Lung Cancer And Solid Tumors Carcinoma, Non-Small-Cell Lung, Solid Tumor | Phase 2 | 2016-11-11 |
| Active Not Recruiting | A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib Peritoneal Cancer, Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | 2016-11-10 |
| Active Not Recruiting | Window Study of Nivolumab With or Without Ipilimumab in Squamous Cell Carcinoma of the Oral Cavity Head and Neck Cancer | Phase 2 | 2016-11-01 |
| Completed | A Phase II Trial If Nivolumab, Lenalidomide and Dexamethasone in High Risk Smoldering Myeloma Smoldering Multiple Myeloma | Phase 2 | 2016-10-20 |
| Completed | Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy Prostate Cancer | Phase 2 | 2016-10-19 |
| Completed | A Study of LY2606368 (Prexasertib) in Patients With Solid Tumors With Replicative Stress or Homologous Repair Advanced Cancers | Phase 2 | 2016-10-12 |
| Completed | Pembrolizumab in Metastatic Anal Cancer Anal Cancer | Phase 2 | 2016-10-11 |
| Completed | Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lympho Lymphoma, Neuroblastoma, Brain Tumor | Phase 1 | 2016-10-01 |
| Completed | Trial of Combination of Ixazomib and Lenalidomide and Dexamethasone in Smoldering Multiple Myeloma Smoldering Multiple Myeloma | Phase 2 | 2016-10-01 |
| Completed | A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Cond Multiple Myeloma, Non-Hodgkin's Lymphoma | N/A | 2016-10-01 |
| Active Not Recruiting | A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibi Brain Cancer | Phase 1 | 2016-09-21 |
| Completed | Pembrolizumab Combined With PLD For Recurrent Platinum Resistant Ovarian, Fallopian Tube Or Peritoneal Cancer Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer | Phase 2 | 2016-09-15 |
| Completed | Palbociclib With Everolimus + Exemestane In BC Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Hormone Receptor (HR)-Positive Breast Cancer | Phase 1 / Phase 2 | 2016-08-24 |
| Active Not Recruiting | Matched Targeted Therapy For High-Risk Leukemias and Myelodysplastic Syndrome Recurrent, Refractory, or High Risk Leukemias, Matched Targeted Therapy | N/A | 2016-08-17 |
| Completed | Study of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma Advanced Non-Clear Cell Kidney Cancer | Phase 2 | 2016-07-15 |
| Withdrawn | Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Mali Liver Cancer | Phase 4 | 2016-07-01 |
| Terminated | A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma | Phase 1 | 2016-06-15 |
| Completed | A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcin Carcinoid Tumors | Phase 2 | 2016-06-14 |
| Completed | Implementation of a System-level Tobacco Treatment Intervention Smoking Cessation, Lung Cancer | N/A | 2016-06-01 |
| Terminated | Rapid Plasma Genotyping For Early Initiation Of Erlotinib In EGFR Mutant Lung Cancer Epidermal Growth Factor Receptor, Non-Small Cell Lung Cancer | Phase 2 | 2016-06-01 |
| Active Not Recruiting | Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS) Breast Cancer | Phase 2 | 2016-05-24 |
| Completed | Study of ABT-199 (GDC-199) In Patients With Relapsed Or Refractory Waldenström Macroglobulinemia Waldenstrom Macroglobulinemia | Phase 2 | 2016-05-09 |
| Active Not Recruiting | The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Cons Breast Cancer Radiation | Phase 2 | 2016-05-01 |
| Active Not Recruiting | ACY-1215 in Combination With BCR Pathway Inhibitors in Relapsed CLL Recurrent Chronic Lymphoid Leukemia | Phase 1 | 2016-05-01 |
| Withdrawn | MRI Iron Oxide Imaging for Lymph Node Staging in Esophageal Cancer Esophageal Cancer | Phase 1 | 2016-05-01 |
| Withdrawn | Evaluation Of Lymph Nodes After Neoadjuvant Chemotherapy Breast Cancer | N/A | 2016-04-26 |
| Completed | Avoiding Growth Factor During Paclitaxel Treatment in Breast Cancer Early Stage Breast Cancer | Phase 2 | 2016-04-07 |
| Completed | Study Of Weight-Based Versus Standard Dose Enoxaparin Thromboprophylaxis In High-Risk Hospitalized Cancer Pati Venous Thormboembolism | Phase 2 | 2016-04-01 |
| Completed | An Open-Label, Phase Ib/II Clinical Trial Of Cdk 4/6 Inhibitor, Ribociclib (Lee011), In Combination With Trast Breast Cancer | Phase 1 / Phase 2 | 2016-03-09 |
| Recruiting | Hereditary Risk Factors for Thyroid Cancer Thyroid Cancer | N/A | 2016-03-01 |
| Active Not Recruiting | An Open-Label Phase II Study of Nivolumab or Nivolumab/Ipilimumab in Adult Participants With Progessive/ Recur Meningiomas | Phase 2 | 2016-03-01 |
| Completed | Gut Decontamination In Pediatric Allogeneic Hematopoietic Hematopoietic Stem Cell Transplantation (HSCT), Acute GVH Disease | Phase 2 | 2016-03-01 |
| Completed | A Selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer Prostate Cancer | Phase 2 | 2016-02-29 |
| Active Not Recruiting | A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cance Inflammatory Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Phase 2 | 2016-02-26 |
| Completed | Improving Surgical Decision-making in Young Women With Breast Cancer Breast Cancer | — | 2016-02-19 |
| Completed | Novel Social Media Intervention For Older Br CA Patients Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III | N/A | 2016-02-08 |
| Withdrawn | BAY 1000394 for MCL-1-, MYC-, and CCNE1-Amplified Tumors Solid Tumor | Phase 2 | 2016-02-01 |
| Completed | Study of Ibrutinib in Patients With Symptomatic, Previously Untreated Waldenstrom's Macroglobulinemia, and Imp Waldenstrom's Macroglobulinemia | Phase 2 | 2016-01-01 |
| Active Not Recruiting | A Study Using Regorafenib as Second or Third Line Therapy in Metastatic Medullary Thyroid Cancer Thyroid Cancer | Phase 2 | 2016-01-01 |
| Completed | CBTI-CS: A Novel Cognitive-Behavioral Treatment for Insomnia in Cancer Survivors Insomnia | N/A | 2015-12-01 |
| Completed | Phase II Study of Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone Therapy for N Multiple Myeloma | Phase 2 | 2015-12-01 |
| Active Not Recruiting | A Study of Ibrutinib + Obinutuzumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukemia | Phase 1 | 2015-12-01 |
| Active Not Recruiting | Study Evaluating a Stereotactic Boost/Treatment for Recurrent or Metastatic Cancer of the Head and Neck Recurrent Head and Neck Carcinoma, Head and Neck Cancer Metastatic, Head or Neck Cancer | Phase 1 | 2015-11-01 |
| Completed | MLN0128 in Recurrent/Metastatic Merkel Cell Carcinoma Merkel Cell Carcinoma | Phase 1 / Phase 2 | 2015-10-01 |
| Terminated | Study of Phosphatidylinositol-3-kinase (PI3K) Inhibitor Idelalisib (GS-1101) in Waldenström Macroglobulinemia Waldenstrom's Macroglobulinemia | Phase 2 | 2015-10-01 |
| Active Not Recruiting | The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study Pediatric Solid Tumor | — | 2015-10-01 |
| Completed | The Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or DCIS in Patients Diagnosed Wit Flat Epithelia Atypia, Intraductal Papilloma Without Atypia | N/A | 2015-09-01 |
| Active Not Recruiting | Lenalidomide for Adult Histiocyte Disorders Langerhans Cell Histiocytosis (LCH), Histiocytoses Erdheim-chester Disease, Histiocytic Sarcoma (HS) | Phase 2 | 2015-08-01 |
| Terminated | Harnessing the Effect of an Open-Label Placebo on Fatigue in Cancer Survivors Fatigue in Cancer Survivors | N/A | 2015-08-01 |
| Completed | Trial of Ponatinib in Patients With Bevacizumab-Refractory Glioblastoma Glioblastoma | Phase 2 | 2015-07-13 |
| Completed | A Study of Palbociclib in Combination With Bazedoxifene in Hormone Receptor Positive Breast Cancer Breast Cancer Stage IV, Unresectable Locally Advanced Invasive Breast Cancer, Metastatic Invasive Breast Cancer | Phase 1 / Phase 2 | 2015-07-09 |
| Completed | A Phase I/II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer and Incurably Poorly Differentiated or R Anaplastic Thyroid Cancer, Thyroid Cancer, Differentiated Thyroid Cancer | Phase 1 / Phase 2 | 2015-07-01 |
| Completed | Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning Prostate Cancer, Adenocarcinoma of the Prostate Stage I, Adenocarcinoma of the Prostate Stage II | N/A | 2015-07-01 |
| Completed | Improving Informed Consent for Palliative Chemotherapy Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer, Unresectable Pancreatic Cancer | N/A | 2015-06-10 |
| Completed | A Study to Optimize Care for Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery (VATS) Lung Cancer | — | 2015-06-01 |
| Completed | Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma | EARLY_Phase 1 | 2015-06-01 |
| Completed | Study of Bortezomib,Lenalidomide,Dexamethasone & Elotuzumab in Newly Diagnosed MM Multiple Myeloma | Phase 2 | 2015-05-07 |
| Withdrawn | Pilot Study of Novel Fluorescence Endoscopic Device for Sentinel Lymph Node Mapping in Lung Cancer Lung Cancer | N/A | 2015-05-01 |
| Terminated | Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis Stage III Ovarian Cancer, Stage IV Ovarian Cancer | N/A | 2015-05-01 |
| Active Not Recruiting | Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis and LCH-related Di Langerhans Cell Histiocytosis | Phase 2 | 2015-05-01 |
| Completed | Bone Mineral Density Status in Pediatric and Adolescent Survivors of Childhood Cancer With History of Bone Fra Bone Mineral Density, Childhood Cancer Survivors | — | 2015-05-01 |
| Completed | Pembrolizumab After ASCT for Hodgkin Lymphoma, DLBCL and T-NHL Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Peripheral T-Cell Lymphoma | Phase 2 | 2015-04-01 |
| Completed | Exploratory Study of Radium-223 and VEGF-Targeted Therapy in Patients With Metastatic Renal Cell Carcinoma and Metastatic Renal Cell Carcinoma | Phase 1 | 2015-04-01 |
| Completed | Trial of Ixazomib, Dexamethasone and Rituximab in Patients With Untreated Waldenstrom's Macroglobulinemia Waldenstrom's Macroglobulinemia | Phase 2 | 2015-04-01 |
| Completed | Pembrolizumab +/- Bevacizumab for Recurrent GBM Glioblastoma | Phase 2 | 2015-02-09 |
| Completed | A Phase II Trial of Low-Dose Interleukin-2 (IL-2) Added to Extra-Corporeal Photopheresis for Steroid-Refractor Chronic Graft-versus-host-disease | Phase 2 | 2015-02-01 |
| Completed | Evaluating Mass Spectrometry And Intraoperative MRI In The Advanced Multimodality Image Guided Operating Suite Early Stage Breast Cancer, Breast Cancer Stage I, Breast Cancer Stage II | N/A | 2015-02-01 |
| Completed | Study of Individual Adult and Pediatric Patient Dose-escalated Interleukin-2 Therapy for Refractory Chronic GV Chronic Versus Graft Host Disease | Phase 1 | 2015-02-01 |
| Completed | Patient-Centered Care for the Older Adult With Hematologic Malignancy Hematologic Malignancy | N/A | 2015-02-01 |
| Completed | Image-guided Cryoablation of Head, Neck and Spine Tumors Head and Neck Neoplasms, Malignant Neoplasm of Vertebral Column | N/A | 2015-02-01 |
| Completed | Phase II Trial of Natalizumab + Prednisone for Initial Therapy of Acute GI GVHD Graft Versus Host Disease | Phase 2 | 2015-01-01 |
| Active Not Recruiting | T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA HER-2 Positive Breast Cancer, Breast Cancer, Stage II Breast Cancer | Phase 2 | 2015-01-01 |
| Completed | E-PRISM: Phase II Trial of Elotuzumab Lenalidomide and Dexamethasone in High-Risk Smoldering Multiple Myeloma Smoldering Myeloma, Smoldering Multiple Myeloma | Phase 2 | 2014-12-11 |
| Completed | A Phase 2 Clinical Trial of Rituxan and B-Glucan PGG in Relapsed Indolent Non-Hodgkin Lymphoma Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphomas | Phase 2 | 2014-12-01 |
| Active Not Recruiting | Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM Glioblastoma | Phase 1 | 2014-11-01 |
| Completed | Cabozantinib +/- Trastuzumab In Breast Cancer Patients w/ Brain Metastases Breast Cancer, Brain Tumor - Metastatic | Phase 2 | 2014-11-01 |
| Completed | A Phase I/Ib Safety and Efficacy Study of the PI3K-delta Inhibitor TGR-1202 and Ibrutinib in Patients With CLL Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Mantle Cell Lymphoma | Phase 1 | 2014-11-01 |
| Completed | Sexual Therapy and Rehabilitation After Treatment for Ovarian Cancer (START-OC): A Pilot Intervention Ovarian Cancer | N/A | 2014-11-01 |
| Completed | Impact of Cerebellar Mass Resection on Pain Processing Cerebellar Neoplasm | — | 2014-10-01 |
| Active Not Recruiting | A Phase II Study of Ibrutinib Plus FCR in Previously Untreated, Younger Patients With Chronic Lymphocytic Leuk Chronic Lymphocytic Leukemia, Leukemia | Phase 2 | 2014-10-01 |
| Completed | Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate Prostate Adenocarcinoma, Prostate Cancer, High Risk Prostate Cancer | Phase 2 | 2014-10-01 |
| Completed | Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Carcinoma, Squamous Cell of Head and Neck, HPV Positive Oropharyngeal Squamous Cell Carcinoma, Hypopharyngeal Cancer | Phase 1 | 2014-09-29 |
| Completed | Everolimus for Cancer With TSC1 or TSC2 Mutation TSC1, TSC2, Tuberous Sclerosis Complex | Phase 2 | 2014-09-01 |
| Recruiting | Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Ou Monoclonal Gammopathy of Undetermined Significance (MGUS), Myelodysplastic Syndromes, Hematological Malignancies | — | 2014-08-01 |
| Completed | Crizotinib in Combination With Enzalutamide in Metastatic Castration-resistant Prostate Cancer Castration-resistant Prostate Cancer | Phase 1 | 2014-08-01 |
| Completed | Personal Web Page In Clinical Trial Participant Education Prostate Cancer, Kidney Cancer, Genitourinary Cancer | N/A | 2014-07-21 |
| Recruiting | Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases Stage, Colon Cancer, Stage I-III Colon Cancer, Stage IV Colon Cancer With Resectable Liver Metastases | EARLY_Phase 1 | 2014-07-14 |
| Recruiting | A Prospective Study of Plasma Genotyping as a Noninvasive Biomarker for Genotype-directed Cancer Care NSCLC, Melanoma | — | 2014-07-03 |
| Completed | Phase Ib Study of SUnitinib Alternating With REgorafenib in Patients With Metastatic and/or Unresectable GIST Gastrointestinal Stromal Tumor | Phase 1 | 2014-07-01 |
| Completed | Study of Omalizumab as Adjuvant Therapy in Chemotherapy Desensitization Drug Allergy | Phase 1 | 2014-07-01 |
| Terminated | An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Ho Chronic Graft-versus-Host-Disease, Oral Mucosal Disease Due to Graft-versus-host Disease | Phase 2 | 2014-07-01 |
| Active Not Recruiting | A Phase 1b/2 Study of IPI-145 Plus FCR in Previously Untreated, Younger Patients With CLL Chronic Lymphocytic Leukemia | Phase 1 / Phase 2 | 2014-06-27 |
| Completed | A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients Taxane-induced Peripheral Neuropathy, Chemotherapy-induced Peripheral Neuropathy (CIPN), Early-Stage Breast Carcinoma | N/A | 2014-06-01 |
| Completed | A Study of Idelalisib (GS1101, CAL101) + Ofatumumab in Previously Untreated CLL/SLL Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 2 | 2014-06-01 |
| Terminated | Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer Invasive Breast Cancer (Stage I-III), Ductal Carcinoma in Situ, Lobular Carcinoma in Situ | Phase 2 | 2014-05-01 |
| Completed | Cisplatin vs Paclitaxel for Triple Negative Breast Cancer Triple Negative Breast Cancer | Phase 2 | 2014-04-01 |
| Completed | Feasibility Study of Low Level Light Therapy for Prevention of Oropharyngeal Mucositis in Pediatric Transplant Oropharyngeal Mucositis, Myeloablative Hematopoietic Cell Transplantation, Low Level Light Therapy | N/A | 2014-04-01 |
| Active Not Recruiting | Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML Relapsed Acute Lymphoblastic Leukemia (ALL), Refractory Acute Lymphoblastic Leukemia (ALL), Relapsed Acute Myelogenous Leukemia (AML) | Phase 1 | 2014-03-01 |
| Terminated | Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma Merkel Cell Carcinoma, Skin Cancer | Phase 2 | 2014-02-01 |
| Completed | Enzalutamide + External Beam Rt For Prostate Intermediate Risk Prostate Cancer | Phase 2 | 2014-02-01 |
| Completed | Ruxolitinib W/ Preop Chemo For Triple Negative Inflammatory Brca Recurrent Breast Cancer, Metastatic Breast Cancer | Phase 1 / Phase 2 | 2014-02-01 |
| Completed | Study of Abiraterone Acetate Without Exogenous Glucocorticoids in Men With Castration-resistant Prostate Cance Castration-resistant Prostate Cancer | Phase 2 | 2014-01-27 |
| Completed | PALBOCICLIB + PD-0325901 for NSCLC & Solid Tumors KRAS Mutant Non-Small Cell Lung Cancer, Solid Tumors | Phase 1 | 2014-01-01 |
| Completed | Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasi Breast Cancer | Phase 2 | 2014-01-01 |
| Completed | PET/CT-Assessment of Liver Tumor Ablation Liver Tumor, Liver Neoplasms | N/A | 2014-01-01 |
| Completed | Early Changes In Multiparametric MRI In Prostate Cancer Prostate Cancer | N/A | 2013-12-01 |
| Active Not Recruiting | Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disea Chronic Graft Versus Host Disease, Chronic GVHD, Complications of Organ Transplant Stem Cells | Phase 1 | 2013-11-01 |
| Completed | Healthy Living After Cancer: Weight Management Pilot Study Weight Loss Program After Cancer Diagnosis | N/A | 2013-11-01 |
| Terminated | Tivozanib As Maintenance Therapy In GYN Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma | Phase 2 | 2013-11-01 |
| Completed | A Phase I Study Of Panobinostat/Lenalidomide/Bortezomib/Dex for Relapsed And Relapsed/Refractory Multiple Myel Multiple Myeloma in Relapse | Phase 1 | 2013-10-01 |
| Completed | Genomic and Psychosocial Effects of the 3RP on Patients With MGUS and Smoldering Multiple Myeloma Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma | N/A | 2013-10-01 |
| Terminated | GSK1120212+GSK2141795 for Cervical Cancer Cervical Cancer | Phase 2 | 2013-10-01 |
| Completed | Study of Enzalutamide in Patients With Castration-resistant Prostate Cancer Metastatic Castration-resistant Prostate Cancer | Phase 2 | 2013-09-13 |
| Completed | A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostat Prostate Cancer | N/A | 2013-09-01 |
| Terminated | Phase II Study of Eribulin Mesylate, Trastuzumab, and Pertuzumab in Women With Metastatic, Unresectable Locall HER2-positive Breast Cancer, Metastatic Breast Cancer | Phase 2 | 2013-09-01 |
| Completed | Impact of Radiation Therapy on Breast Conservation in DCIS DCIS | — | 2013-08-01 |
| Completed | ARRY-380 + Trastuzuamab for Breast w/ Brain Mets Brain Metastases From HER2 and Breast Cancer, Advanced HER2-positive Breast Cancer | Phase 1 | 2013-08-01 |
| Completed | Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa Breast Cancer | Phase 2 | 2013-08-01 |
| Completed | Personal Patient Profile - Prostate (P3P) II: Effectiveness-Implementation Trial in Diverse Health Care Networ Prostate Cancer | N/A | 2013-08-01 |
| Terminated | A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma T-Cell Lymphoma, Relapsed T-Cell Lymphoma, Refractory T-Cell Lymphoma | EARLY_Phase 1 | 2013-07-01 |
| Completed | A Phase II Trial of Regadenoson in Sickle Cell Anemia Sickle Cell Anemia | Phase 2 | 2013-07-01 |
| Terminated | CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma T-cell Non-Hodgkin Lymphoma | Phase 2 | 2013-07-01 |
| Completed | NIR-Guided Sentinel Lymph-Node Mapping for Esophageal Cancer Esophageal Cancer | Phase 1 | 2013-06-21 |
| Completed | Dendritic Cell Activating Scaffold in Melanoma Melanoma | Phase 1 | 2013-06-01 |
| Withdrawn | Tivozanib + Gemcitabine in Metastatic RCC Renal Cell Carcinoma | Phase 2 | 2013-06-01 |
| Completed | Eribulin in HER2 Negative Metastatic BrCa Breast Cancer | Phase 2 | 2013-05-01 |
| Active Not Recruiting | Parental Decision-Making for Children With Relapsed Neuroblastoma Relapsed Neuroblastoma | — | 2013-05-01 |
| Completed | T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial) Breast Cancer | Phase 2 | 2013-05-01 |
| Completed | Sunitinib in Never-Smokers With Lung Adenocarcinoma Lung Cancer | Phase 2 | 2013-05-01 |
| Completed | Ziv-Aflibercept for Advanced Progressive Carcinoid Tumors Carcinoid Tumor | Phase 2 | 2013-02-13 |
| Completed | Cabozantinib for Metastatic Triple Negative BrCa Breast Cancer | Phase 2 | 2013-02-01 |
| Completed | Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer Squamous Cell Carcinoma of the Head and Neck | Phase 1 | 2013-02-01 |
| Terminated | GVAX vs. Placebo for MDS/AML After Allo HSCT Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia | Phase 2 | 2013-01-08 |
| Completed | Standard of Care vs. Bortezomib in Graft-Versus Host Disease After Hematopoietic Stem Cell Transplant Graft Versus Host Disease | Phase 2 | 2013-01-01 |
| Completed | FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer Esophageal Cancer, Gastric Cancer | Phase 2 | 2013-01-01 |
| Terminated | Ponatinib for Squamous Cell Lung and Head and Neck Cancers Non-Small Cell Lung Cancer, Head and Neck Cancer | Phase 2 / Phase 3 | 2013-01-01 |
| Active Not Recruiting | INHERIT EGFR - Studying Germline EGFR Mutations Lung Cancer | — | 2012-12-28 |
| Terminated | Feasibility Study of Enhanced MRI for Early Stage Non Small Cell Lung Cancer (NSCLC) Non Small Cell Lung Cancer | N/A | 2012-11-01 |
| Terminated | BKM120+Abiraterone Acetate for Metastatic CRPC Prostate Cancer | Phase 1 | 2012-11-01 |
| Completed | Cisplatin + RT for Triple Negative Breast Cancer Breast Cancer | Phase 1 | 2012-10-01 |
| Completed | Whole-Exome Sequencing (WES) of Cancer Patients Lung Adenocarcinoma, Colon Adenocarcinoma | — | 2012-09-01 |
| Withdrawn | Ferumoxytol-Enhanced MRI in Adult/Pedi Sarcomas Soft Tissue Sarcoma | N/A | 2012-09-01 |
| Completed | Healthy Directions After Lung Surgery Pilot Carcinoma, Non Small Cell Lung | N/A | 2012-09-01 |
| Completed | Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patient Ovarian Cancer, Breast Cancer | Phase 1 | 2012-09-01 |
| Active Not Recruiting | Rituximab/Bendamustine + Rituximab/Cytarabine for Mantle Cell Lymphoma Mantle Cell Lymphoma | Phase 2 | 2012-08-16 |
| Completed | iCAT for Recurrent/Refractory/HR Solid Tumors Pediatric Solid Tumor, Sarcoma, Neuroblastoma | — | 2012-08-01 |
| Withdrawn | Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer | Phase 2 | 2012-08-01 |
| Completed | Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors Carcinoid Tumor, Pancreatic Neuroendocrine Tumor | Phase 2 | 2012-07-01 |
| Active Not Recruiting | SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma | Phase 2 | 2012-06-01 |